Clinical trial
An Immunogenicity and Safety Evaluation of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered to Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age.
NCT01659996 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Immunogenicity and Safety Evaluation of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered to Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age.
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- September 30, 2015
- Enrollment
- 1,394 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.
diphtheria, haemophilus influenzae serotype b (hib), meningitis, meningococcal infection, pertussis, tetanus